Welcome to VERCIDA website.

Skip to main content
Enable Recite to make this website accessible

0%
Profile completeness

Did you know that users who have filled in their profile details are 42 times more likely to get matched with the right employer?

security illustration Help us find the best workplace for you by sharing more about yourself. We will never disclose your information with others.

CSR at GlaxoSmithKline

“GSK has a strong commitment to operating responsibly and playing our part in meeting some of society’s biggest healthcare challenges. Over the past decade, this has been seen in our commitment to place access to medicines at the centre of our business approach, in our innovation focused on diseases that impact the poorest countries – such as malaria – and in the changes we have made to our commercial model and sales and marketing practices.” – Sir Andrew Witty, Chief Executive Officer

Our mission is to help people do more, feel better and live longer. We do this by researching and developing medicines, vaccines and consumer healthcare products that improve people’s lives. By growing our business and extending access to our medicines, we are ensuring long-term commercial success as well as improving people’s health, creating value for our shareholders and delivering economic benefits to society.

Operating responsibly also supports our ability to attract and retain talent, build trust with patients and consumers, our customers, payers and stakeholders who influence our licence to operate. GSK contributes directly and indirectly to economic growth in more than 150 countries, through tax, charitable support and employing 99,300 people.

We have well-established, long-term responsible commitments which sit across four areas: Health for all, Our behaviour, Our people and Our planet. We established our priorities in these areas through a comprehensive materiality assessment to identify the issues that are most important to our stakeholders and have the most impact on our business success.

In 2016, we reviewed and validated this analysis, using a range of sources including employee feedback, investor insights, the UN’s Sustainable Development Goals and our global reputation research. We also conducted in-depth interviews with representatives of our key stakeholder groups including: patient advocacy groups, NGOs, peer groups, investors and think tanks and academia. All material issues were considered in relation to our commercial strategy and their impact on the business.

 

You will receive an email with link to reset your password.

Enter your new password